Literature DB >> 15469877

Involvement of alpha7- and alpha4beta2-type postsynaptic nicotinic acetylcholine receptors in nicotine-induced excitation of dopaminergic neurons in the substantia nigra: a patch clamp and single-cell PCR study using acutely dissociated nigral neurons.

Hiroaki Matsubayashi1, Atsuko Inoue, Taku Amano, Takahiro Seki, Yoshihiro Nakata, Masashi Sasa, Norio Sakai.   

Abstract

The receptor subtypes, which mediate nicotine-induced excitation of dopaminergic neurons in the substantia nigra, were investigated by whole-cell patch clamp studies and single-cell RT-PCR using acutely dissociated nigral neurons. Three types of current were observed when acetylcholine (1 mM) was applied to the neurons in the presence of atropine (1 microM) by the U-tube system, which allowed the rapid application of drugs. In 50% of neurons examined, acetylcholine (1 mM) plus atropine (1 microM) evoked a current with a rapidly desensitizing decay phase (designated as type Ia current). In 14% of neurons tested, the current induced by acetylcholine plus atropine had a decay phase with slow desensitization (designated as type II current). The third type of response, which had both characteristics of type Ia and II currents, was evoked in 36% of neurons tested (designated as type Ib currents). Nicotine (1 mM) also induced three types of inward currents which were similar to those induced by acetylcholine (1 mM) plus atropine (1 microM). In all three types of current, nicotine (0.1 microM-1 mM)-evoked inward currents were dose-dependent. Type Ia and II currents were inhibited by methyllycaconitine (MLA, 0.01 microM), a selective nicotinic alpha7 receptor antagonist, and dihydro-beta-erythroidine (DHbetaE, 0.1 microM), an antagonist for alpha4beta2 receptor, respectively. In type Ib currents, a fast-decaying phase was inhibited by MLA (0.01 microM), while a slow-decaying phase was blocked by DHbetaE (0.1 microM). After recording the type Ib current, single-cell RT-PCR analysis was performed using aspirated cytoplasm as total RNA templates. The results revealed that mRNAs for alpha7 nicotinic receptor subunit and tyrosine hydroxylase were detected in the same single neuron tested, which confirms the existence of alpha7-type nicotinic acetylcholine receptor in dopaminergic neurons of this area. These results suggest that nicotine directly acts on postsynaptic alpha7- and alpha4beta2-type nicotinic acetylcholine receptors and induces inward current, which result in the excitation of dopaminergic neurons in the substantia nigra.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15469877     DOI: 10.1016/j.molbrainres.2004.06.040

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  14 in total

1.  Nicotine upregulates the expression of P2Y12 on vascular cells and megakaryoblasts.

Authors:  Gouri Shanker; Jimmy L Kontos; Delrae M Eckman; Deborah Wesley-Farrington; David C Sane
Journal:  J Thromb Thrombolysis       Date:  2006-12       Impact factor: 2.300

Review 2.  Nicotine and hippocampus-dependent learning: implications for addiction.

Authors:  Thomas J Gould
Journal:  Mol Neurobiol       Date:  2006-10       Impact factor: 5.590

3.  Developmental regulation of nicotinic acetylcholine receptors within midbrain dopamine neurons.

Authors:  L Azam; Y Chen; F M Leslie
Journal:  Neuroscience       Date:  2006-12-29       Impact factor: 3.590

4.  Alpha 7 nicotinic acetylcholine receptor expression and activity during neuronal differentiation of PC12 pheochromocytoma cells.

Authors:  Arthur A Nery; Rodrigo R Resende; Antonio H Martins; Cleber A Trujillo; Vesna A Eterovic; Henning Ulrich
Journal:  J Mol Neurosci       Date:  2010-05-12       Impact factor: 3.444

Review 5.  Nicotine and inflammatory neurological disorders.

Authors:  Wen-Hua Piao; Denise Campagnolo; Carlos Dayao; Ronald J Lukas; Jie Wu; Fu-Dong Shi
Journal:  Acta Pharmacol Sin       Date:  2009-05-18       Impact factor: 6.150

6.  Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology.

Authors:  Filip Simunovic; Ming Yi; Yulei Wang; Laurel Macey; Lauren T Brown; Anna M Krichevsky; Susan L Andersen; Robert M Stephens; Francine M Benes; Kai C Sonntag
Journal:  Brain       Date:  2008-12-03       Impact factor: 13.501

7.  Distinctive nicotinic acetylcholine receptor functional phenotypes of rat ventral tegmental area dopaminergic neurons.

Authors:  Kechun Yang; Jun Hu; Linda Lucero; Qiang Liu; Chao Zheng; Xuechu Zhen; Guozhang Jin; Ronald J Lukas; Jie Wu
Journal:  J Physiol       Date:  2008-12-01       Impact factor: 5.182

8.  Functional alpha7-containing nicotinic acetylcholine receptors localize to cell bodies and proximal dendrites in the rat substantia nigra pars reticulata.

Authors:  Olga V Poisik; Jian-xin Shen; Susan Jones; Jerrel L Yakel
Journal:  J Physiol       Date:  2008-03-01       Impact factor: 5.182

Review 9.  Nicotinic receptor-based therapeutics and candidates for smoking cessation.

Authors:  Linda P Dwoskin; Andrew M Smith; Thomas E Wooters; Zhenfa Zhang; Peter A Crooks; Michael T Bardo
Journal:  Biochem Pharmacol       Date:  2009-06-10       Impact factor: 5.858

10.  Effect of traumatic brain injury on nicotine-induced modulation of dopamine release in the striatum and nucleus accumbens shell.

Authors:  Yuan-Hao Chen; Tung-Tai Kuo; Eagle Yi-Kung Huang; Yu-Ching Chou; Yung-Hsiao Chiang; Barry J Hoffer; Jonathon Miller
Journal:  Oncotarget       Date:  2018-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.